Fulltext

In-vitro activity of roxithromycin against respiratory and skin pathogens

Pechère, J.-C ; Auckenthaler, R.

In: Journal of Antimicrobial Chemotherapy, 1987, vol. 20, p. 1-5

Ajouter à la liste personnelle
    Titre
    • In-vitro activity of roxithromycin against respiratory and skin pathogens
    Auteur
    • Pechère, J.-C. Département de Microbiologie, CMU, 9, Avenue de Champel, 1211 Genève 4, Switzerland
    • Auckenthaler, R.. Département de Microbiologie, CMU, 9, Avenue de Champel, 1211 Genève 4, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Journal of Antimicrobial Chemotherapy, 1987, vol. 20, p. 1-5. Oxford University Press
    Autre version électronique
    Classification
    • Santé
    Mots clés
    Identifiant OAI-PMH
    • oai:doc.rero.ch:303290
    Summary
    The activity of roxithromycin was determined by a microdilution method, in comparison with erythromycin, spiramycin and josamycin. Roxithromycin and erythromycin showed very similar MICs against staphylococci, Streptococcus pneumoniae, Str. pyogenes and Haemophilia influenzae. In most cases, spiramycin and josamycin appeared similarly or more active. The activity of roxithromycin against Mycoplasma pneumoniae, Legionella spp., Chlamydia psittaci and, to some extent, against Pasteurella spp. was also assessed, by suitable in-vitro methods. Roxithromycin has a promising potential for treating selected skin and respiratory infections